Differential Effects of Levosimendan and Dobutamine on Glomerular Filtration Rate in Patients With Heart Failure and Renal Impairment:A Randomized Double‐Blind Controlled Trial
Lukas Lannemyr, Sven‐Erik Ricksten, Bengt Rundqvist, Bert Andersson, Sven‐Erik Bartfay, Charlotta Ljungman, Pia Dahlberg, Niklas Bergh, Clara Hjalmarsson, Thomas Gilljam, Entela Bollano, Kristjan Karason;Lukas Lannemyr;Sven‐Erik Ricksten;Bengt Rundqvist;Bert Andersson;Sven‐Erik Bartfay;Charlotta Ljungman;Pia Dahlberg;Niklas Bergh;Clara Hjalmarsson;Thomas Gilljam;Entela Bollano;Kristjan Karason;
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2018Vol. 7pp. -
137
karason2018journaldifferential
Abstract
The management of the cardiorenal syndrome in advanced heart failure is challenging, and the role of inotropic drugs has not been fully defined. Our aim was to compare the renal effects of levosimendan versus dobutamine in patients with heart failure ...